News articles

News article list

• Routine NHS access to spinal muscular atrophy treatments offers new hope for patients and families

  People living with spinal muscular atrophy (SMA) in England are set to gain routine access to two potentially life-changing treatments, following our publication of final draft guidance today.

• Neonatal infection guidance updated to allow home antibiotic treatment for some babies

  We’ve recommended that newborn babies receiving antibiotics in hospital could potentially switch to oral antibiotics and be cared for at home if they are doing well and responding to treatment.

• NICE approves Duchenne muscular dystrophy treatment givinostat after commercial deal sealed

  Around 530 people in England will benefit from access to the Duchenne muscular dystrophy treatment givinostat, following the successful negotiation of a commercial deal to make the medicine available on the NHS.

• 'I no longer feel asthmatic': more than a million people now using new style inhalers

  The change follows a landmark guideline published jointly in 2024 by NICE, the British Thoracic Society (BTS) and the Scottish Intercollegiate Guidelines Network (SIGN).

• NICE appoints Dr Adrian Hayter as its new chief medical officer

  Dr Adrian Hayter joins NICE from the Royal College of General Practitioners bringing more than three decades of frontline clinical and national leadership experience to the role.